Botelho-Santos GA, Sampaio WO, Reudelhuber TL, Bader M, Campagnole-Santos MJ, Santos RAS. Expression of an angiotensin-(1-7)-producing fusion protein in rats induced marked changes in regional vascular resistance. Am J Physiol Heart Circ Physiol 292: H2485-H2490, 2007. First published January 5, 2007; doi:10.1152/ajpheart.01245.2006.-We have described a transgenic rat line that expresses an angiotensin-(1-7)-producing fusion protein, the TGR(A1-7)3292. In these rats, testis acts as an angiotensin-(1-7) biological pump, increasing its plasma concentration 2.5-fold. In this study, we performed hemodynamic measurements in TGR(A1-7)3292 and age-matched Hannover SpragueDawley (SD) control rats, using fluorescent microspheres. Urethaneanesthetized transgenic rats had similar levels of baseline blood pressure (99 Ϯ 3 mmHg) as did SD rats (101 Ϯ 3 mmHg). However, pronounced differences were observed in other hemodynamic measurements. TGR(A1-7)3292 rats presented a significant increase in stroke volume (0.29 Ϯ 0.01 vs. 0.25 Ϯ 0.01 ml in SD), increased cardiac index (24.6 Ϯ 0.91 vs. 21.9 Ϯ 0.65 ml ⅐ min Ϫ1 ⅐ kg) and decreased total peripheral resistance (3.9 Ϯ 0.13 vs. 4.5 Ϯ 0.13 mmHg ⅐ ml Ϫ1 ⅐ min ⅐ 100 g). The increase in stroke volume in transgenic rats may be partially explained by the small decrease in heart rate (326 Ϯ 7.0 vs. 359 Ϯ 6.0 beats/min in SD). Strikingly, TGR(A1-7)3292 rats presented a substantial decrease in the vascular resistance in lung, spleen, kidney, adrenals, brain, testis and brown fat tissue with no significant differences in the left ventricle, mesentery, skin, gastrocnemius muscle and white fat tissue. These results corroborate and extend previous results observed after acute angiotensin-(1-7) infusion, showing that chronic increase in circulating angiotensin-(1-7) produces sustained and important changes in regional and systemic hemodynamics. Moreover, our data suggest a physiological role for angiotensin-(1-7) in the tonic control of regional blood flow.
THE HEPTAPEPTIDE angiotensin-(1-7) [ANG- (1) (2) (3) (4) (5) (6) (7) ] is now considered one of the biologically active end products of the renin-angiotensin system (RAS) (8, 14, 17, 44, 45) . It can be formed from ANG II through hydrolysis by angiotensin-converting enzyme 2, prolylendopeptidase, or prolylcarboxypeptidase (8, 10, 17, 20, 44, 57) or directly from ANG I through hydrolysis by prolylendopeptidase and endopeptidase 24.11 (8, 14, 20, 43, 58, 60) . ANG-(1-7) can be also formed from ANG-(1-9) formed by hydrolysis of ANG I by angiotensinconverting enzyme 2 (8, 17, 20, 45) .
The blood vessels are an important site for the opposing actions of ANG II and ANG- (1) (2) (3) (4) (5) (6) (7) . Vascular responses to ANG-(1-7) significantly differ from those induced by ANG II. Contrasting with ANG II, ANG-(1-7) in blood vessels acts mainly as a vasodilatador and antiproliferative hormone (24, 44, 48) . ANG-(1-7) was shown to produce relaxation of aortic rings of Sprague-Dawley (SD) (53) and mRen-2 transgenic rats (29) , canine (4) and porcine coronary arteries (39) , canine middle cerebral artery (23) , piglet pial arterioles (33) , feline systemic vasculature (38) , rabbit renal afferent arterioles (40) , and mesenteric microvessels of normotensive and hypertensive rats (16, 37) . In anesthetized rats ANG-(1-7) induces vasodilatation in various vascular beds and an increase in stroke volume and cardiac index (41) .
Many studies have shown that the vascular actions of ANG-(1-7) appear to involve increased production of vasodilators, prostanoids, nitric oxide (NO) and endothelium-derived hyperpolarizing factor (15, 27, 36, 39, 42) and that the relative importance of these mechanisms is dependent on the vessel diameter, the vascular regional bed, and the species (44) . Moreover, some vascular effects involve simultaneous participation of these vasodilator mediators. A cross talk between ANG-(1-7) receptors and other receptors such as kinin B 2 and ANG II type 2 receptors may also activate these pathways in blood vessels (45) . In addition, the vascular actions of ANG-(1-7) could involve modulation of ANG II-induced changes in vascular resistance (45) .
There are few studies examining the effect of chronic increases in plasma ANG-(1-7) concentration (2, 3, 52, 59) . In these studies ANG-(1-7) was administrated using osmotic mini-pumps for periods no longer than 15 days (2, 3, 59) . Thus information on the effect of chronic increase in ANG-(1-7) is still missing. Data in this regard are particularly important considering that several pharmacological and nonpharmacological measures for treating hypertension and other cardiovascular diseases produce chronic increases in plasma ANG-(1-7) concentration (7) . It has been recently described that peptides can be directly released within specific tissues from an engineered fusion protein by proteolytic action of the furin enzyme (34, 35) . This technique provided a possibility to increase the release of peptides in defined tissues or a particular cell line (35) . With this strategy, transgenic mice have been produced expressing an ANG II-producing fusion protein exclusively in cardiac myocytes or astrocytes (31, 55) . We have recently described a transgenic rat expressing an ANG-(1-7)-producing fusion pro-tein in testis. In these rats, TGR(A1-7)3292 (TGR), there is a 2.5-fold increase in plasma ANG-(1-7) concentration (19, 46) . Sampaio et al. (41) demonstrated that acute infusion of ANG-(1-7) changed the regional blood flow distribution, increased the cardiac output (CO), and decreased total peripheral resistance (TPR) in Wistar rats. Considering these data, we hypothesized that chronic increase in ANG-(1-7), as observed in transgenic rats, could also change the systemic and regional hemodynamic. To test this hypothesis, we performed systemic and regional hemodynamic measurements in TGR rats using fluorescent microspheres.
MATERIALS AND METHODS

Animals and Surgical Preparation
Male SD and TGR rats 3-4 mo old were housed in cages and maintained in a temperature-regulated room (22-24°C) on a 12-h:12-h light-dark cycle (lights on at 6:00 AM). ANG-(1-7) plasma levels in SD and TGR are 17.6 Ϯ 0.9 and 43.6 Ϯ 13.1 pg/ml, respectively (47) .
Rats were anesthetized with urethane (1.2 g/kg ip; Sigma). A tracheostomy was performed to keep airway patency. Body temperature, continually monitored with a rectal probe, was kept at 36 -37°C by a heating pad. The left braquial artery was cannulated with polyethylene tubing (PE-10) for recording of blood pressure and heart rate (Power Lab 4/20 ADInstruments/Bridge Amp Panlab S.J., Spain). For administration of fluorescent microspheres, the right carotid artery was exposed, and a PE-50 cannula was guided through the common carotid artery into the left ventricle. The positioning of the cannula in the left ventricle was confirmed by recording the typical ventricular pressure. The right femoral artery was cannulated and connected to a pump (Minipuls 3, Gilson; Villiers le Bel, France) for blood withdrawal. The right femoral vein was also cannulated for infusion of vehicle (0.9% NaCl). The experimental procedures used in this study are in accordance with the recommendations of the Guide for the Care and Use of Laboratory Animals, published by the National Institutes of Health (NIH Publication No. 85-23, Revised 1996) and were approved by the Animal Committee of the Federal University of Minas Gerais (CETEA).
Determination of Systemic and Regional Hemodynamics
Systemic hemodynamics and regional blood flow were determined using 15-m fluorescent polystyrene microspheres (FluoSpheres Blood Flow Determination, Molecular Probes; Eugene, OR) as previously reported (25, 26, 41) . Briefly, two different colors of fluorescent microspheres were used for two consecutive measurements to control for the reproducibility of the measurement. The color of microspheres was selected to avoid the spillover between the colors (26) . To prevent aggregation, the microspheres suspension was vortexed for 2 min, followed by sonication for an additional 60 s. After the mixing was completed, 300,000 fluorescent microspheres were infused into the left ventricle over a 10-s period. To calculate the blood flow, arterial blood was withdrawn at a rate of 0.85 ml/min through the right femoral artery. Blood for reference blood sample was withdrawn for 90 s starting 10 s before the microsphere injection. The same procedure was repeated with the second color 10 min after the first one. At the end of the experiment the animals were euthanized with an overdose of anesthetic, and the tissues (kidneys, brain, mesentery, adrenals, spleen, abdominal skin, gastrocnemius muscle, lungs, testis, left ventricle, brown and white fat) were dissected, weighed, and stored in individual vials. Both tissue and reference blood samples were digested using a solution of a 4 M ethanolic KOH containing 2% Tween 80 in a hot bath (50°C) overnight. At the end of the digestion period the microspheres were recovered by the sedimentation method (56) , and the dye was extracted in 4 ml of the organic solvent ethyl acetate. The fluorescence intensity of the dye was measured using a spectrophotometer (Cary Eclipse Fluorescence Spectrophotometer/Varian). The following parameters were calculated: CO (ml/ min), cardiac index (in ml ⅐ min Ϫ1 ⅐ 100 g), stroke volume (in ml), TPR (in mmHg ⅐ ml Ϫ1 ⅐ min ⅐ 100 g), regional blood flow (ml ⅐ min Ϫ1 ⅐ g), and regional vascular resistance (mmHg ⅐ ml Ϫ1 ⅐ min ⅐ g) as previously described (25, 26, 56) .
Data Analysis
Data are presented as means Ϯ SE. Statistical comparisons were assessed by Student's t-test. Values of P Ͻ 0.05 were considered significant. Figure 1 shows the averaged values of cardiac index, stroke volume, and TPR of urethane-anesthetized SD (n ϭ 20) and TGR (n ϭ 19). The TGR showed a cardiac index (24.59 Ϯ 0.91 ml⅐min Ϫ1 ⅐100 g Ϫ1 ) and stroke volume (0.29 Ϯ 0.01 ml) significantly higher than that observed in SD rats (21.98 Ϯ 0.65 ml⅐min Ϫ1 ⅐100 g Ϫ1 and 0.25 Ϯ 0.01 ml, respectively; P Ͻ 0.05, Student's t-test). Consequently, a significant smaller TPR was observed in TGR (3.95 Ϯ 0.13 mmHg⅐ml Ϫ1 ⅐min⅐100 g) in comparison to SD rats (4.55 Ϯ 0.13 mmHg⅐ml Ϫ1 ⅐min⅐100 g; P Ͻ 0.05, Student's t-test). Mean arterial pressure was similar between the two groups of rats (TGRϭ 99 Ϯ 3 mmHg and SD ϭ 101 Ϯ 3 mmHg). However, the heart rate was slightly smaller in TGR (326 Ϯ 7 beats/min) in comparison to SD (359 Ϯ 6 beats/min) rats. These differences remained the same after the second measurement, repeated 10 min after the first one (data not shown). Table 1 and Fig. 2 present the values of blood flow and vascular resistance, respectively, in the different regions stud- ied in SD and TGR rats. As shown in Fig. 2 , the vascular resistance in the kidney, adrenals, testis, brain, lung, spleen and brown fat were substantially smaller in the TGR rats as compared with their age-matched controls. There were no statistically significant differences in the vascular resistance in the left ventricle, muscle, skin, mesentery and white fat (Fig. 2) . The changes in vascular resistance were paralleled by an increase in blood flow in lung, spleen, renal, adrenals, cerebral, testis, and brown fat territories of the TGR rats compared with control rats (Table 1) . The blood flow differences between SD and TGR rats remained the same in a second measurement repeated 10 min after the first one (data not shown).
RESULTS
Systemic Hemodynamic of SD and TGR Rats
Regional Blood Flow and Vascular Resistance of SD and TGR Rats
DISCUSSION
Several studies have demonstrated that the blood vessels are an important site for the formation and actions of ANG-(1-7) (41, 43, 44, 48) . Our results, which are in keeping with a previous study in Wistar rats (41) , indicate that ANG-(1-7) has an effective and important role in the tonic control of blood flow distribution.
Chronic increase in ANG-(1-7) observed in TGR rats produced pronounced changes in regional blood flow, resulting in an increase in vascular conductance in the kidneys, lungs, adrenals, spleen, brain, testis and brown fat tissue. The potent and selective effect of ANG-(1-7) in several territories confirms and extends previous observations using acute infusion of ANG-(1-7) (41). The cardiac index of TGR rats was 12% higher than that of SD rats, which can be explained, at least in part, by the smaller TPR (13%) of TGR rats.
We have found that the chronic increase in endogenous ANG-(1-7) in TGR rats produced a higher blood flow in the brain. The blood flow was 17% higher and vascular resistance was 26% smaller in the TGR brain as compared with agematched control SD rats. This observation is in agreement with a previous study by Meng and Busija (33) demonstrating a vasodilatory effect of ANG-(1-7) in piglet pial arterioles. The TGR rats also presented a smaller vascular resistance and a higher blood flow than SD rats in testis. This observation is in agreement with previous studies showing the presence of the RAS in the reproductive organs and its involvement in the physiology of this reproductive system (9, 30) . Additionally, Alenina et al. (1) demonstrated a well-controlled regulation of Mas expression in testis beginning 18 days after birth and increasing until 6 mo of age. This continuous increase in Mas mRNA level indicated that Mas is not just involved in the maturation process of testis but may be also implicated in the function of the mature organ. Our results suggest that one of the roles of Mas in testis is the modulation of blood flow.
The discovery of a local adipose-tissue RAS has allowed the detection of a pathophysiological role for the RAS in obesityassociated disturbances and insulin resistance, as well as a function in the secretion of adipocytes-derived products (13) . Aditionally, ANG I, ANG II and ANG-(2-8) have been detected in rat brown adipose tissue (BAT) (5, 6, 13, 50), suggesting endogenous production, mainly of ANG II. In this study, we found a marked difference between blood flow in BAT of TGR and SD rats. BAT blood flow was 156% higher and vascular resistance 53% smaller in TGR rats. This observation indicates that BAT is a major target for ANG- (1-7) . Whether the differences in blood flow are secondary to an effect of ANG-(1-7) in BAT metabolic rate, a direct effect on BAT microvessels or a combination of both factors remains to be established.
The influence of ANG-(1-7) in the renal functions is complex and depends on the hydroelectrolytic status, the renal sympathetic nervous activity, and the level of activity of the RAS (19, 22, 48, 51) . Accumulating evidence suggests that apart from ANG II, ANG-(1-7) plays a significant role in renal function. ANG-(1-7) increases renal blood flow in anesthetized rats (41) and produces afferent arteriolar relaxation through specific receptor-mediated NO release in isolated kidneys of rabbits (40) . In addition to the effects on renal blood flow, studies in vitro and in awake animals have suggested that ANG-(1-7) can act as a natriuretic/diuretic or antidiuretic hormone depending of the hydroelectrolytic status (28, 48) . Our results extend these observations and suggest that ANG-(1-7) can importantly modulate renal blood flow. It should be pointed out that in a recent study, van der Wouden et al. (54) did not observe an effect of ANG-(1-7) on renal blood flow in freely moving rats. However, the doses used by these authors (133, 333, and 667 ng⅐kg Ϫ1 ⅐min Ϫ1 ) were substantially higher than that used by Sampaio et al. (41) Sampaio et al. (41) observed that acute infusion of ANG-(1-7) in Wistar rats increased the blood flow to skin and did not change the blood flow to spleen, adrenal and lung. In contrast, we observed that the chronic increase in ANG-(1-7) levels in the TGR produced a significant increase in the blood flow to adrenal, spleen and lung without changing the blood flow to skin. These discrepant findings may be related to many factors including acute versus chronic changes in plasma ANG-(1-7), differences between rat strains or the possibility of changes in the expression of enzymes and/or receptors, which may be involved in regional blood flow distribution, produced by chronic increase in circulating ANG- (1-7) .
Another interesting observation with the chronic increase in ANG-(1-7) levels was the smaller TPR of TGR rats, which may have contributed to the increase in stroke volume leading to an increase in CO. On the other hand, the opposite changes in TPR and CO could explain the absence of substantial changes in blood pressure in response to ANG-(1-7) as described previously (2, 3, 41) . The higher CO of TGR rats is probably also related to the slightly smaller heart rate combined with a possible increase in venous return, which, in turn, could be the consequence of the vasodilatation in several territories, including cerebral, renal, spleen, BAT, adrenal, pulmonary and testis vascular beds. However, a direct inotropic effect of ANG-(1-7) cannot be excluded. Our recent observations in rats and in Mas-deficient mice are in keeping with this later possibility (46, 47) .
Perspectives
Our results indicate that discrete changes in circulating ANG-(1-7) may produce important variations in the regional and systemic hemodynamic. More importantly, our results indicate that the hemodynamic changes produced are sustained, suggesting a hitherto unsuspected important physiological role for ANG-(1-7) in the tonic control of blood flow.
Many of the cardiovascular effects of ANG-(1-7) are completely blocked by the selective ANG-(1-7) antagonist A-779, suggesting that the effects of ANG-(1-7) on the blood vessels are mediated by a specific receptor sensitive to A-779 (23, 24) . Recently, Santos et al. (49) reported that ANG-(1-7) is an endogenous ligand for the G protein-coupled receptor Mas. Future studies should address the possibility of the involvement of the ANG-(1-7) receptor Mas in the hemodynamic effects of ANG-(1-7) by using A-779 and receptor Mas knockout mice. In addition, the local contribution of NO, prostaglandins, and endothelium-derived relaxing factor as well as the central nervous system to the changes in blood flow observed should be explored in future studies. 
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